Literature DB >> 23404405

Lactate dehydrogenase A is overexpressed in pancreatic cancer and promotes the growth of pancreatic cancer cells.

Yefei Rong1, Wenchuan Wu, Xiaoling Ni, Tiantao Kuang, Dayong Jin, Dansong Wang, Wenhui Lou.   

Abstract

The prognosis for pancreatic cancer is very poor, and developing new therapeutic strategies for this cancer is needed. Recently, the Warburg effect (aerobic glycolysis) has attracted much attention for its function in the tumorigenesis. Lactate dehydrogenase A (LDHA) executes the final step of aerobic glycolysis and has been reported to be involved in the tumor progression. However, the function of LDHA in pancreatic cancer has not been studied. Here, we found that the expression of LDHA was elevated in the clinical pancreatic cancer samples. Forced expression of LDHA promoted the growth of pancreatic cancer cells, while knocking down the expression of LDHA inhibited cell growth dramatically. Moreover, silencing the expression of LDHA inhibited the tumorigenicity of pancreatic cancer cells in vivo. Mechanistically, knocking down the expression of LDHA activated apoptosis pathway. Taken together, our study revealed the oncogenic role of LDHA in pancreatic cancer and suggested that LDHA might be a potential therapeutic target.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23404405     DOI: 10.1007/s13277-013-0679-1

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  16 in total

Review 1.  Progression model for pancreatic cancer.

Authors:  R H Hruban; M Goggins; J Parsons; S E Kern
Journal:  Clin Cancer Res       Date:  2000-08       Impact factor: 12.531

Review 2.  Pancreatic cancer.

Authors:  Manuel Hidalgo
Journal:  N Engl J Med       Date:  2010-04-29       Impact factor: 91.245

Review 3.  Pancreatic carcinoma.

Authors:  A L Warshaw; C Fernández-del Castillo
Journal:  N Engl J Med       Date:  1992-02-13       Impact factor: 91.245

4.  Resected adenocarcinoma of the pancreas-616 patients: results, outcomes, and prognostic indicators.

Authors:  T A Sohn; C J Yeo; J L Cameron; L Koniaris; S Kaushal; R A Abrams; P K Sauter; J Coleman; R H Hruban; K D Lillemoe
Journal:  J Gastrointest Surg       Date:  2000 Nov-Dec       Impact factor: 3.452

5.  c-Myc transactivation of LDH-A: implications for tumor metabolism and growth.

Authors:  H Shim; C Dolde; B C Lewis; C S Wu; G Dang; R A Jungmann; R Dalla-Favera; C V Dang
Journal:  Proc Natl Acad Sci U S A       Date:  1997-06-24       Impact factor: 11.205

6.  Knockdown of lactate dehydrogenase A suppresses tumor growth and metastasis of human hepatocellular carcinoma.

Authors:  Shi L Sheng; Jian J Liu; Yun H Dai; Xiao G Sun; Xiao P Xiong; Gang Huang
Journal:  FEBS J       Date:  2012-09-13       Impact factor: 5.542

7.  A combined proteomics and metabolomics profiling of gastric cardia cancer reveals characteristic dysregulations in glucose metabolism.

Authors:  Zhen Cai; Jiang-Sha Zhao; Jing-Jing Li; Dan-Ni Peng; Xiao-Yan Wang; Tian-Lu Chen; Yun-Ping Qiu; Ping-Ping Chen; Wen-Jie Li; Li-Yan Xu; En-Ming Li; Jason P M Tam; Robert Z Qi; Wei Jia; Dong Xie
Journal:  Mol Cell Proteomics       Date:  2010-08-10       Impact factor: 5.911

Review 8.  Why do cancers have high aerobic glycolysis?

Authors:  Robert A Gatenby; Robert J Gillies
Journal:  Nat Rev Cancer       Date:  2004-11       Impact factor: 60.716

9.  LDHA is necessary for the tumorigenicity of esophageal squamous cell carcinoma.

Authors:  Feng Yao; Tiejun Zhao; Chenxi Zhong; Ji Zhu; Heng Zhao
Journal:  Tumour Biol       Date:  2012-09-08

10.  Cancer statistics, 2009.

Authors:  Ahmedin Jemal; Rebecca Siegel; Elizabeth Ward; Yongping Hao; Jiaquan Xu; Michael J Thun
Journal:  CA Cancer J Clin       Date:  2009-05-27       Impact factor: 508.702

View more
  67 in total

Review 1.  Small-molecule inhibitors of human LDH5.

Authors:  Carlotta Granchi; Ilaria Paterni; Reshma Rani; Filippo Minutolo
Journal:  Future Med Chem       Date:  2013-10       Impact factor: 3.808

2.  Screening of novel inhibitors targeting lactate dehydrogenase A via four molecular docking strategies and dynamics simulations.

Authors:  Rong Sun; Xin Li; Yuanyuan Li; Xun Zhang; Xinru Li; Xiaoyu Li; Zheng Shi; Jinku Bao
Journal:  J Mol Model       Date:  2015-05-02       Impact factor: 1.810

3.  Stable shRNA Silencing of Lactate Dehydrogenase A (LDHA) in Human MDA-MB-231 Breast Cancer Cells Fails to Alter Lactic Acid Production, Glycolytic Activity, ATP or Survival.

Authors:  Nzinga Mack; Elizabeth A Mazzio; David Bauer; Hernan Flores-Rozas; Karam F A Soliman
Journal:  Anticancer Res       Date:  2017-03       Impact factor: 2.480

4.  FOXM1 promotes the warburg effect and pancreatic cancer progression via transactivation of LDHA expression.

Authors:  Jiujie Cui; Min Shi; Dacheng Xie; Daoyan Wei; Zhiliang Jia; Shaojiang Zheng; Yong Gao; Suyun Huang; Keping Xie
Journal:  Clin Cancer Res       Date:  2014-03-14       Impact factor: 12.531

5.  The molecular mechanism and clinical significance of LDHA in HER2-mediated progression of gastric cancer.

Authors:  Weiyou Zhu; Ling Ma; Jing Qian; Jin Xu; Tongpeng Xu; Lijun Pang; Hong Zhou; Yongqian Shu; Jianwei Zhou
Journal:  Am J Transl Res       Date:  2018-07-15       Impact factor: 4.060

Review 6.  Role of abnormal lipid metabolism in development, progression, diagnosis and therapy of pancreatic cancer.

Authors:  Julian Swierczynski; Areta Hebanowska; Tomasz Sledzinski
Journal:  World J Gastroenterol       Date:  2014-03-07       Impact factor: 5.742

7.  Discovery and Optimization of Potent, Cell-Active Pyrazole-Based Inhibitors of Lactate Dehydrogenase (LDH).

Authors:  Ganesha Rai; Kyle R Brimacombe; Bryan T Mott; Daniel J Urban; Xin Hu; Shyh-Ming Yang; Tobie D Lee; Dorian M Cheff; Jennifer Kouznetsova; Gloria A Benavides; Katie Pohida; Eric J Kuenstner; Diane K Luci; Christine M Lukacs; Douglas R Davies; David M Dranow; Hu Zhu; Gary Sulikowski; William J Moore; Gordon M Stott; Andrew J Flint; Matthew D Hall; Victor M Darley-Usmar; Leonard M Neckers; Chi V Dang; Alex G Waterson; Anton Simeonov; Ajit Jadhav; David J Maloney
Journal:  J Med Chem       Date:  2017-11-09       Impact factor: 7.446

8.  Silencing LDHA inhibits proliferation, induces apoptosis and increases chemosensitivity to temozolomide in glioma cells.

Authors:  Hui Di; Xinting Zhang; Yi Guo; Yanfang Shi; Chuan Fang; Yu Yuan; Jiwei Wang; Chao Shang; Wenzhe Guo; Chunhui Li
Journal:  Oncol Lett       Date:  2018-02-02       Impact factor: 2.967

9.  Expression of SIP1 is strongly correlated with LDHA and shows a significantly poor outcome in gastric cancer.

Authors:  Xuren Sun; Zhe Sun; Zhi Zhu; Chenyan Li; Junyan Zhang; Huimian Xu; Mingjun Sun
Journal:  Tumour Biol       Date:  2015-04-26

10.  LDH5 overexpression is associated with poor survival in patients with solid tumors: a meta-analysis.

Authors:  YanHong Yao; HaiTao Wang; BaoGuo Li
Journal:  Tumour Biol       Date:  2014-04-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.